10x Genomics Reports Second Quarter 2025 Financial Results
PLEASANTON, Calif., Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,...
Pharmaceutical
10x Genomics to Acquire Scale Biosciences
Acquisition Will Further Expand Chromium's Capabilities PLEASANTON, Calif., Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in...
RETRANSMISSION: Skineez(R) Debuts First-Ever Reversible Medical Grade Compression – A Game-Changer Made in the USA, Defying Tariffs and Redefining Retail Wellness
Skineez® Launches First-Ever Reversible Medical Grade Compression Sock-Made in the USAClinically Proven, Skincare-Infused, and Changing Lives Nationwide SUDBURY, MA /...
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results
Revenues increased 18% compared to same period last yearU.S. revenue increased 57% compared to same period last yearNet loss per...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
- Reports Net Revenues of $174.4 million for the Three Months Ended June 30, 2025- GAAP net income of $31.0...
Skineez(R) Launches First-Ever Reversible Medical Grade Compression Sock-Made in the USA
Skineez®, a proudly woman-owned wellness apparel brand, has just launched a revolutionary new product: the EZ Comfort™ Reversible Medical Grade...
Brain Computer Interface Market to Soar from USD 1.6 Billion in 2024 to USD 6.3 Billion by 2033, at 20.5% CAGR – Market Research Intellect
The Brain Computer Interface (BCI) market is experiencing rapid growth due to increasing advancements in neurotechnology, rising demand for assistive...
Hospital PMI® at 51%; July 2025 Hospital ISM® Report On Business®
TEMPE, Ariz., Aug. 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector expanded in July after one month of contraction, preceded...
Spinogenix Announces Positive First Cohort Results from Phase 2a Trial Evaluating SPG302 for Alzheimer’s Disease
SPG302, a Potential First-in-Class Synaptic Regenerative Therapy, Showed Progress in Cognitive Outcome Measures and a Favorable Safety Profile LOS ANGELES,...
StratifyMDX Announces Meraki
StratifyMDX Announces Meraki - The Most Advanced Intelligent Health Agent for Proactive, Personalized Care BOULDER, CO / ACCESS Newswire /...
Sinceri Senior Living Adds Six Communities to Expanding Footprint Through Strategic Partnership With National Health Investors
VANCOUVER, WASHINGTON / ACCESS Newswire / August 7, 2025 / Sinceri Senior Living is proud to announce a strategic expansion...
Alta AI Debuts New 3D Perio Index Tool That Drives SRP Acceptance
Groundbreaking Visual Tool Designed to Help Hygienists Communicate More Clearly and Convert More Treatment LEHI, UTAH / ACCESS Newswire /...
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
For the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESS...
Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
New data from Eurofins Discovery show that Telomir-1 blocks enzymes that drive disease by turning off critical genes-highlighting its potential...
Smile Digital Health Maintains Key Certifications in Security, Privacy, and Compliance
Continued ISO 27001, 27017, 27018, 13485, SOC 2 Type 2, and HITRUST Certification Reflects Ongoing Commitment to Trusted Health Data...
Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative.The $1 million is part of up to...
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights
PMV will host an investor webinar on Wednesday, September 10, 2025 at 8:00 AM ET to review Phase 2 PYNNACLE...
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or...
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification
- Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07,...
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next...